<DOC>
	<DOCNO>NCT01055366</DOCNO>
	<brief_summary>The purpose study assess safety efficacy switch ELAZOP prior pharmacotherapy patient open-angled glaucoma .</brief_summary>
	<brief_title>ELAZOP Switching Study Korea</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>18 year age old . Clinical diagnosis ocular hypertension , primary openangle pigment dispersion glaucoma eye . Must stable regimen Intraocular Pressure ( IOP ) lower medication ( i.e. , either single therapeutic agent two separate ocular hypotensive agent ) least one month prior Screening Visit . Must IOP consider safe ( opinion investigator ) , eye , way assure clinical stability vision optic nerve throughout study period . Must willing discontinue use ocular hypotensive medication prior receive study medication entire course study . Other protocoldefined inclusion criterion may apply . Known medical history allergy , hypersensitivity , poor tolerance component preparation use study deem clinically significant opinion Principal Investigator . Intraocular conventional surgery laser surgery either eye less three month prior Screening visit . History ocular herpes simplex . Pregnant lactating . Participation investigational study within 30 day Screening visit . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Open angle glaucoma</keyword>
	<keyword>OAG</keyword>
	<keyword>Elazop</keyword>
	<keyword>Azarga</keyword>
	<keyword>Brinzolamide/Timolol combination</keyword>
</DOC>